Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-18 06:15 am Sale |
2022-01-14 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 0 0.000% |
-475,856 (Position Closed) |
Filing History |
| 2022-01-18 06:12 am Purchase |
2022-01-13 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 475,856 5.980% |
193,267 (+68.39%) |
Filing History |
| 2021-11-24 09:13 am Sale |
2021-11-24 | 13G | Minerva Neurosciences, Inc. NERV |
Assenagon Asset Management S.A. | 173,186 3.240% |
-586,978 (-77.22%) |
Filing History |
| 2021-11-24 09:11 am Purchase |
2021-11-23 | 13G | Minerva Neurosciences, Inc. NERV |
Assenagon Asset Management S.A. | 760,164 14.230% |
760,164 (New Position) |
Filing History |
| 2020-08-06 11:13 am Purchase |
2020-06-17 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 282,589 6.390% |
222,819 (+372.79%) |
Filing History |
| 2020-08-06 11:13 am Purchase |
2020-06-18 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 59,771 1.070% |
59,771 (New Position) |
Filing History |
| 2020-08-04 11:27 am Sale |
2020-08-04 | 13G | Impinj, Inc. PI |
Assenagon Asset Management S.A. | 413,869 1.810% |
-762,338 (-64.81%) |
Filing History |
| 2020-08-04 08:48 am Purchase |
2020-08-03 | 13G | Impinj, Inc. PI |
Assenagon Asset Management S.A. | 1,176,207 5.150% |
527,411 (+81.29%) |
Filing History |
| 2020-06-24 12:25 pm Sale |
2020-06-23 | 13G | LendingClub Corporation LC |
Assenagon Asset Management S.A. | 2,096,071 3.000% |
-1,651,200 (-44.06%) |
Filing History |
| 2020-06-24 12:17 pm Purchase |
2020-06-19 | 13G | LendingClub Corporation LC |
Assenagon Asset Management S.A. | 3,747,271 5.360% |
3,747,271 (New Position) |
Filing History |
| 2020-06-19 10:20 am Sale |
2020-06-18 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 59,771 1.070% |
-222,819 (-78.85%) |
Filing History |
| 2020-06-19 10:18 am Purchase |
2020-06-17 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 282,589 6.390% |
282,589 (New Position) |
Filing History |
| 2020-06-17 11:54 am Unchanged |
2020-06-15 | 13G | Affimed N.V. AFMD |
Assenagon Asset Management S.A. | 78 1.020% |
0 (Unchanged) |
Filing History |
| 2020-06-16 10:59 am Sale |
2020-06-15 | 13G | Affimed N.V. AFMD |
Assenagon Asset Management S.A. | 78 1.020% |
-497,934 (-99.98%) |
Filing History |
| 2020-06-16 10:55 am Purchase |
2020-06-12 | 13G | Affimed N.V. AFMD |
Assenagon Asset Management S.A. | 498,012 6.530% |
498,012 (New Position) |
Filing History |